Abiopharma

🔍 Parekh Sonalee Elizabeth (Executive)

Company: SentinelOne, Inc. (S)

Report Date: 2026-04-15

Detailed Transactions and Holdings:

• Acquired 1,011,091 shares of Class A Common Stock (Direct)
  Date: 2026-04-15 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,011,091.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents a grant of restricted stock units ("RSUs") that shall vest as to 10% of the total award on July 5, 2026 (the "First Vesting Date") and thereafter 10% of the RSUs will vest on each third Vesting Date following the First Vesting Date until an additional 30% of the RSUs have vested; then (iii) 6.25% of the RSUs will vest on each third Vesting Date thereafter until an additional 25% of the RSUs have vested; then (iv) 5% of the RSUs will vest on each third Vesting Date thereafter until an additional 20% of the RSUs have vested; and finally (v) 3.75% of the RSUs will vest on the 5th of November, February, May, and August, until fully vested, subject to the Reporting Person's continued service through each vesting date.
• F2: Certain of the shares are subject to forfeiture to the Issuer if underlying vesting conditions are not met.